Microarray detection range on WT-amplified samples.

<p><b>NOTE</b>. Conc, Concentration; SN, supernatant; RVFV, Rift-Valley fever virus; WNV13-01, sample from QCMD EQA WNV panel 13-01; WNV, West Nile virus; JEV, Japanese encephalitis virus; TBEV, tick borne encephalitis virus; DENV13-01, sample from QCMD EQA DENV panel 13-01; DENV, Dengue virus; HCV, hepatitis C virus; ND, not detected; na, not analysed.</p>§<p>WNV13-10 contain additional viruses (DENV-1, DENV-2 and DENV-4).</p>#<p>WNV13-11 contain addition viruses (YFV, DENV-3).</p>95<p>results obtained using a 95 percentile threshold.</p>a<p>copies/ml (HCV; IU/ml).</p>b<p>ml (volume of sample for purification).</p>c<p>Number of copies into reaction.</p><p>*Difference in C_t-value in real-time PCR before and after WT amplification.</p><p>+Fold increase after WT amplification, calculated from ΔC_t combined with dilution factors for each sample.